ALB and venous thromboembolism: Recent studies on COVID-19 infection also revealed that higher baseline albumin was associated with lower severity of COVID-19 infection and fewer adverse outcomes, including the requirement of ICU admission, development of acute respiratory distress syndrome, incident venous thromboembolism, and readmissions within 90 days [29, 30].